Gelatinases
-
Subject Areas on Research
- A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2.
- Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
- Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro.
- Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
- Fibroblast activation protein, a potential diagnostic and therapeutic target for cancer-reply.
- Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
- Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).
- Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain.
- Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression.
- Structural remodelling in heart failure: gelatinase induction.
- Suppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice.
- Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.